VINCERX PHARMA INC's ticker is VINC and the CUSIP is 92731L106. A total of 44 filers reported holding VINCERX PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $103,069 | -22.3% | 102,049 | 0.0% | 0.03% | -5.9% |
| Q2 2023 | $132,664 | +25.0% | 102,049 | 0.0% | 0.03% | -34.6% |
| Q1 2023 | $106,131 | +2.0% | 102,049 | 0.0% | 0.05% | +36.8% |
| Q4 2022 | $104,090 | -26.2% | 102,049 | 0.0% | 0.04% | -15.6% |
| Q3 2022 | $141,000 | +4.4% | 102,049 | 0.0% | 0.04% | -11.8% |
| Q2 2022 | $135,000 | -66.9% | 102,049 | 0.0% | 0.05% | -62.2% |
| Q1 2022 | $408,000 | -60.8% | 102,049 | 0.0% | 0.14% | -57.0% |
| Q4 2021 | $1,040,000 | -37.0% | 102,049 | 0.0% | 0.31% | -40.3% |
| Q3 2021 | $1,650,000 | -9.8% | 102,049 | -27.6% | 0.53% | +15.6% |
| Q2 2021 | $1,830,000 | -9.7% | 140,913 | +34.2% | 0.46% | +10.7% |
| Q1 2021 | $2,027,000 | -35.3% | 105,000 | -29.9% | 0.41% | -36.0% |
| Q4 2020 | $3,134,000 | – | 149,892 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAGE RHINO CAPITAL LLC | 1,658,199 | $2,189,000 | 0.84% |
| Affinity Asset Advisors, LLC | 1,374,098 | $1,814,000 | 0.76% |
| SABBY MANAGEMENT, LLC | 500,559 | $661,000 | 0.45% |
| TANG CAPITAL MANAGEMENT LLC | 1,030,634 | $1,360,000 | 0.21% |
| Rubric Capital Management LP | 2,107,000 | $2,781,000 | 0.15% |
| Long Focus Capital Management, LLC | 980,000 | $1,294,000 | 0.14% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 385,000 | $508,000 | 0.09% |
| Clearline Capital LP | 452,184 | $597,000 | 0.08% |
| Sio Capital Management, LLC | 102,049 | $135,000 | 0.05% |
| Rock Springs Capital Management LP | 814,194 | $1,075,000 | 0.03% |